Davenport Research Laboratories, 80 St George Street, Chemistry Department, University of Toronto, Ontario M5S 3H6, Canada.
Nat Chem. 2017 Jul 25;9(8):731-742. doi: 10.1038/nchem.2814.
Boron-containing molecules have been extensively used for the purposes of chemical sensing, biological probe development and drug discovery. Due to boron's empty p orbital, it can coordinate to heteroatoms such as oxygen and nitrogen. This reversible covalent mode of interaction has led to the use of boron as bait for nucleophilic residues in disease-associated proteins, culminating in the approval of new therapeutics that work by covalent mechanisms. Our analysis of a wide range of covalent inhibitors with electrophilic groups suggests that boron is a unique electrophile in its chameleonic ability to engage protein targets. Here we review boron's interactions with a range of protein side-chain residues and reveal that boron's properties are nuanced and arise from its uncommon coordination preferences. These mechanistic and structural insights should serve as a guide for the development of selective boron-based bioactive molecules.
含硼分子在化学传感、生物探针开发和药物发现等领域得到了广泛应用。由于硼的空 p 轨道,可以与氧和氮等杂原子配位。这种可逆的共价相互作用模式导致硼被用作与疾病相关蛋白中的亲核残基结合的诱饵,最终促成了通过共价机制起作用的新型治疗药物的批准。我们对一系列具有亲电基团的共价抑制剂进行的分析表明,硼是一种独特的亲电试剂,具有变色龙般的能力,可以与蛋白靶标结合。在这里,我们综述了硼与一系列蛋白侧链残基的相互作用,并揭示了硼的性质是微妙的,源于其不同寻常的配位偏好。这些机制和结构上的见解应该可以作为开发选择性硼基生物活性分子的指南。